Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 10:15 PM
Study NCT ID:
NCT05024058
Status:
TERMINATED
Last Update Posted:
2024-06-18
First Post:
2021-08-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-23
First Submit QC Date:
None
Study First Post Date:
2021-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-09
Results First Submit QC Date:
None
Results First Post Date:
2023-09-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-14
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL